Companies · Other Health Care
PLANO · Other Health Care
Diligence memoA one-page analyst read on USRC Premier Midlothian, LLC — recommendation, valuation, rhythm, risks.→USRC Premier Midlothian, LLC looks under-valued against its niche peers and is quiet on financing cadence.
Synthesized from the figures below est. — every claim rests on a number shown on this page. Valuation uses the health care sector profile.
Analyst read est. — computed against this company's niche peers in the same era. Inputs shown; not a quoted figure.
Procedural diagnosis est. — rule-based common-sense checks over the filing pattern, issuer name, activity cadence, and surfaced operating evidence.
USRC Premier Midlothian, LLC behaves more like a recurring private-offering issuer than a conventional venture-backed operating company.
No named principal in this company's public records yet — see all operators below.
Explore how these operators interlock with other companies in the operator network.
USRC Premier Midlothian, LLC is one of 5377 Other Health Care companies tracked from PLANO. By capital raised it ranks mid-pack (ahead of 40% of sector peers), and in the long tail by modeled valuation est..
Ranking is computed against this company's own sector cohort — reported capital is fact; valuation tiers are modeled.
As reported in public records reported — not modeled.
Solid bars are reported offering amounts reported; hatched bars are the modeled post-money valuation est. — both on one shared scale so you can read raise-vs-worth at each round directly. Use the toggles to overlay data labels and the niche-peer / market average value lines.
The line shows cumulative reported funding over the period; + labels show new capital added between points when there is room. Toggle on-bar figures, plus the niche-peer and market averages, to read this company against its cohort. Benchmarks are modeled medians.
Stages are modeled from round size (public records carry no series label). No record for: Pre-Seed — the company may have raised it under a different exemption, merged it into an adjacent record, or skipped it. Sequence completeness: 50%.
Round size and date are reported; the stage label is inferred from round size (latest is Seed — a $1.0M–$4.0M round). Valuation is modeled from stage benchmarks scaled by the health care sector profile. Directional, not a quoted figure.
Not enough modeled valuation points to chart a trajectory.
Benchmarked against 5377 companies in Other Health Care. Each bar is a median (the middle company, not an average — outliers don't skew it). Two yardsticks: real money raised (reported on Form D) and modeled value (our estimate est.). These are whole-sector medians across all stages, except the per-stage row.
Raised more than 40% of sector peers (real $). Modeled value above 22% of peers (estimate).
A tighter cohort than the sector chart above — only companies at the same stage (Seed) that last raised in the same ~3-year era, ranked by modeled value est. (not money raised). This is the exact set the analyst read compares against, so a like-for-like cohort is what makes "over/under-valued" meaningful. This company ranks #204 of 244.
| Company | Stage | Raised · real | Value · est | vs peer med. |
|---|---|---|---|---|
| Elmntri LLC | Seed | $4.0M | $46.1M | 3.83× |
| Atreo, Inc. | Seed | $3.8M | $42.1M | 3.50× |
| descendantsDNA, Inc. | Seed | $3.4M | $40.8M | 3.40× |
| Westover Project Investor LLC | Seed | $4.0M | $40.0M | 3.33× |
| Dentulu Inc | Seed | $6.4M | $37.7M | 3.13× |
| Emmacare.com LLC | Seed | $3.0M | $37.2M | 3.10× |
| IR-Med, Inc. | Seed | $5.4M | $37.0M | 3.08× |
| SDH Parent 2 LLC | Seed | $3.0M | $36.7M | 3.05× |
| TecTraum, Inc. | Seed | $7.8M | $36.7M | 3.05× |
| DBN BCS II Investments, LLC | Seed | $3.0M | $34.0M | 2.83× |
| USRC Baldwin Hills, LLC | Seed | $2.8M | $34.0M | 2.82× |
| Flex Operating Room, Inc. | Seed | $6.2M | $31.9M | 2.65× |
| USRC Premier Midlothian, LLC this company | Seed | $1.3M | $5.4M | 0.45× |
Stage is inferred from round size est., not reported on the filing — a round's dollar size maps to a bucket: Pre-Seed <$1.0M · Seed $1.0M–$4.0M · Series A $4.0M–$15M · Series B $15M–$40M · Series C $40M–$100M · Series D+ $100M–$400M · Growth/Late >$400M.
| Stage | Amount · real | Announced | Post-money · est | Value · est | Conf. |
|---|---|---|---|---|---|
| Seed | $1.3M | 2024-09-12 | $6.7M | $5.4M | 90% |
Step-up, pace versus the sector's normal cadence, and revenue/exemption moves — read straight from the reported round facts reported.
Predictive signals are modeled est. from this company's own cadence and step-up, plus sector benchmarks — directional, not advice. Peer set and a CSV export live in your analyst workspace.
Officers, directors and promoters named in this company's public recordsreported — the people who run it (not its investors). "Also runs" counts come from name-matching across all records, so verify before acting.
| Person | Role | Also runs | Tied since |
|---|---|---|---|
| Thomas L. Weinberg | — | 47 other | 2024-09 |
| Christopher K Skowron | — | 7 other | 2024-09 |
| James K Hilger | — | 7 other | 2024-09 |
| Steven K Nottingham | — | 7 other | 2024-09 |
| Irfan K. Agha | — | — | 2024-09 |
| Mary K. Dittrich | — | — | 2024-09 |
| Srinivasa R. Danda | — | — | 2024-09 |
USRC Premier Midlothian, LLC is an official record sourced from the U.S. Securities and Exchange Commission (SEC). U.S. data is aggregated from SEC Form D filings.
Nearest neighbours across the whole database — matched on sector, stage and capital scale, and on shared operators (officers or directors named at both companies in public filings). A discovery shortlist, not a valuation cohort — verify before acting, the same way modeled figures are directional.
| Company | Sector | Stage | Raised · real | Value · est | Why similar |
|---|---|---|---|---|---|
| USRC Brownsville, LLC | Other Health Care | Seed | $1.4M | $11.1M | network4 shared operators · same sector · same stage |
| Usrc East Atlanta, Llc | Other Health Care | Seed | $1.2M | $3.3M | network4 shared operators · same sector · same stage |
| USRC Fall Creek, LLC | Other Health Care | Seed | $3.1M | $25.0M | network4 shared operators · same sector · same stage |
| USRC Electric City, LLC | Other Health Care | Seed | $3.2M | $25.1M | network4 shared operators · same sector · same stage |
| USRC Hancock-Seneca, LLC | Other Health Care | Seed | $3.4M | $20.2M | network4 shared operators · same sector · same stage |
| USRC Weslaco Central, LLC | Other Health Care | Pre-Seed | $634K | $3.6M | network4 shared operators · same sector |
| USRC Greater Atlanta Home Therapies, LLC | Proptech / Real Estate | Pre-Seed | $180K | $646K | network4 shared operators |
| USRC Compton, LLC | Other Health Care | Seed | $1.4M | $27.4M | network1 shared operator · same sector · same stage |
Matched by meaning, not labels — a local language model reads each company's name, sector and description and ranks the closest in that learned space. This catches look-alikes that cross sector boundaries; the structured list above explains its matches, this one trusts the text. Directional, like every modeled signal here.
| Company | Sector | Stage | Value · est | Match |
|---|---|---|---|---|
| USRC East Dallas, LLC | Other Health Care | Pre-Seed | $30.8M | 88% |
| USRC Ogden, LLC | Other Health Care | Pre-Seed | $22.1M | 88% |
| USRC South York, LLC | Other Health Care | Pre-Seed | $21.2M | 88% |
| Usrc Mhp, Llc | Other Health Care | Seed | $58.2M | 87% |
| USRC Hill Country, LLC | Other Health Care | Pre-Seed | $15.4M | 87% |
| USRC Royal Central, LLC | Other Health Care | Pre-Seed | $20.0M | 87% |
| Usrc Conroe, Llc | Other Health Care | Pre-Seed | $25.7M | 87% |
| USRC Napa, LLC | Other Health Care | Pre-Seed | $15.4M | 87% |
See where USRC Premier Midlothian, LLC sits in the wider market — its sector, location and stage cohorts, each with their own leaderboards and capital-flow timelines.
If you work at USRC Premier Midlothian, LLC, claim this profile or suggest a correction. We aggregate from public filings, so help us keep your description, website and links accurate.
Is this your company? Update your profile or add contact details — and choose exactly who can reach you. Reviewed before anything is published.